Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Experts agree that addiction is a disease, yet the disease model doesn't capture addiction's harmful effects on others.

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing ...

Tirzepatide doesn’t necessarily wear off after 5 days. The half-life of tirzepatide is 5 days, meaning the amount you have in ...

A collaborative study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London has found that the protein ACE2 may play a ...

Adults with obesity and type 2 diabetes who underwent bariatric surgery had greater decreases in HbA1c and body weight than ...

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Your patient may be doing everything right but still not making progress. But there’s more to it than just A1c.

Friendly" labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

More than a decade ago, GLP-1 drugs began being marketed for weight loss. Sexenda was approved in the U.S. in 2014, and ...

A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to ...

Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...